SDCVF yields 2.82% · MRK yields 2.76%● Live data
📍 SDCVF pulled ahead of the other in Year 3
Combined, SDCVF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SDCVF + MRK for your $10,000?
Vicat S.A. produces and sells cement, ready-mixed concrete, and aggregates. The company operates in three segments: Cement, Concrete & Aggregates, and Other Products & Services. It offers various cement products, including Portland cement, Portland composite cement, blast furnace cement, slag cement, and Pozzolan cement for the general contractors, such as concrete mixers; manufacturers of precast concrete products; construction and public works contractors; local authorities; residential property developers or master masons; and construction material wholesalers or retail chains. The company also provides ready-mixed concrete comprising standard and special concrete for the construction and public works contractors, including construction groups, house building companies, farmers, or private individuals, as well as industrial, commercial buildings, roads, bridges, tunnels, and highways; aggregates, such as sands and gravel products for the ready-mixed concrete and precast concrete products manufacturers. In addition, it offers construction chemicals for use in exterior wall coatings, mortar and traditional concretes, tiling adhesives, and thermal insulation products, as well as for the products used to repair floors and walls; adhesives, and paper bags for the agro-food, chemical, and construction sectors. Further, the company provides various services comprising logistics, transportation, and distribution. It operates in France, Switzerland, Italy, the United States, Turkey, Egypt, Senegal, Mali, Mauritania, Kazakhstan, India, and Brazil. Vicat S.A. was incorporated in 1853 and is headquartered in L'Isle-d'Abeau, France.
Full SDCVF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.